Open-access OCTA tools showed similar reliability, but different vessel density values in glaucoma; researchers advise using one tool consistently.
|Articles|March 29, 2021
Poll results: Are you feeling the effects of burnout?
Author(s)Brooke Henson, Editor
See our latest poll results
Advertisement
Optometry Times® polled our audience with the following question from February 26, 2021 to March 12, 2021:
The poll appeared on
46 ODs responded, in total. Of these:
• 34 responded "Yes"
• 6 responded "No"
• 3 responded "I did in the past but no longer"
• 3 responded "Not personally but I know colleagues who have"
Advertisement
Related to this article
Diana Canto-Sims, OD, introduces the second guest of Season 2, Raphael Rostenne, who will be discussing AI-assisted front desk management.
For Maria Sampalis, OD, implementing AI isn't an excuse for practice owners to replace their staff with new technology; it should instead lift the burden of certain tasks to make for more patient visits.
IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs fell for the first time since tracking began.
Maria Sampalis, OD, discusses her implementation of the EHR software Barti in her practice.
Interim 48-month data show 86% of patients with glaucoma or ocular hypertension remain off topical drops after a single cataract procedure, although the drop-free rate has eased from earlier timepoints.
CLARITY program data show significantly longer time to treatment failure and higher rates of steroid-free quiescence vs placebo.
Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future interventions for patients with AMD.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Brepocitinib for noninfectious uveitis meets all phase 3 trial end points
2
BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial
3
FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours
4
More than monitoring: Using AMD visits to promote healthy vision aging
5